Therapeutic Vaccines Market Insights Report 2020-2024 - Featuring Advantagene, Amgen, Gilead Sciences, Merck & Co, and Novartis Among Others

News provided by

Aug 10, 2020, 07:15 ET

DUBLIN, Aug. 10, 2020 /PRNewswire/ -- The "Global Therapeutic Vaccines Market 2020-2024" report has been added to ResearchAndMarkets.com's offering.

The global therapeutic vaccines market is poised to grow by $3.78 billion during 2020-2024 progressing at a CAGR of 43% during the forecast period.

This report provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors. The report offers an up-to-date analysis regarding the current global market scenario, the latest trends and drivers, and the overall market environment.

The market is driven by the rising incidence and prevalence of diseases, strong therapeutic vaccine pipeline, and increasing funding for the development of vaccines. The study identifies the increase in R&D activities related to novel therapeutic vaccines as one of the prime reasons driving the therapeutic vaccines market growth during the next few years. Also, initiatives to increase awareness about severe diseases and rise in number of strategic alliances will lead to sizable demand in the market.

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading therapeutic vaccines market vendors that include:

Advantagene Inc.
Aimmune Therapeutics Inc.
Amgen Inc.
Gilead Sciences Inc.
Immune Response BioPharma Inc.
Inovio Pharmaceuticals Inc.
Merck & Co. Inc.
Novartis AG
Sanpower Group Co. Ltd.
SOTIO AS

Also, the therapeutic vaccines market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage on all forthcoming growth opportunities.

Key Topics Covered

1. Executive Summary

Market Overview

2. Market Landscape

Market ecosystem
Value chain analysis

3. Market Sizing

Market definition
Market segment analysis
Market size 2019
Market outlook: Forecast for 2019-2024

4. Five Forces Analysis

Five forces summary
Bargaining power of buyers
Bargaining power of suppliers
Threat of new entrants
Threat of substitutes
Threat of rivalry
Market condition

5. Market Segmentation by Type

Market segments
Comparison by Type
Cancer vaccines - Market size and forecast 2019-2024
Infectious diseases vaccines - Market size and forecast 2019-2024
Neurological diseases vaccines - Market size and forecast 2019-2024
Autoimmune diseases vaccines - Market size and forecast 2019-2024
Other diseases vaccines - Market size and forecast 2019-2024
Market opportunity by Type

6. Customer Landscape

Customer landscape

7. Geographic Landscape

Geographic segmentation
Geographic comparison
North America - Market size and forecast 2019-2024
Europe - Market size and forecast 2019-2024
Asia - Market size and forecast 2019-2024
ROW - Market size and forecast 2019-2024
Key leading countries
Market opportunity by geography
Market drivers
Market challenges
Market trends

8. Vendor Landscape

Overview
Landscape disruption

9. Vendor Analysis

Vendors covered
Market positioning of vendors
Advantagene Inc.
Aimmune Therapeutics Inc.
Amgen Inc.
Gilead Sciences Inc.
Immune Response BioPharma Inc.
Inovio Pharmaceuticals Inc.
Merck & Co. Inc.
Novartis AG
Sanpower Group Co. Ltd.
SOTIO AS

For more information about this report visit https://www.researchandmarkets.com/r/xrmldn

Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.

Media Contact:

Research and Markets
Laura Wood, Senior Manager
[email protected]

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

SOURCE Research and Markets